Capricorn Health-tech Fund makes second investment

Leuven, Belgium: 12 May 2011 - Nexstim Oy, a medical device company commercializing non-invasive brain diagnostic and therapy technologies, today announced that it has obtained an additional equity financing of € 2 million, bringing the latest round to € 13.4 million.

The latest investment was made by new investor Capricorn Health-tech Fund NV (Belgium). Capricorn joins current investors HealthCap, LSP (Life Sciences Partners), Sitra and Finnish Industry Investment Ltd, as well as Lundbeckfond Ventures and Ilmarinen in this round. To date, Nexstim has raised over € 30 million.

More info on the press release or on Nexstim's website.